Skip to main content
. 2018 Jan 24;13:133–141. doi: 10.2147/CIA.S153058

Table 1.

Demographic, operative, and clinical data of younger and elderly patients undergoing hepatectomy and pancreaticoduodenectomy

Variables Elderly (≥70 years)
(n=111)
Younger (<70 years)
(n=901)
p-value
Gender, male 81 (73.0%) 619 (68.7%) 0.358
Body mass index 23.5±3.6 22.8±3.2 0.215
Child–Pugh class 0.001
 A 61 (55.0%) 642 (71.3%)
 B 50 (45.0%) 259 (28.7%)
Smoking history 36 (32.4%) 347 (38.5%) 0.215
Diabetes 18 (16.2%) 76 (8.4%) 0.014
Cardiovascular disease 44 (39.6%) 128 (14.2%) <0.001
ASA score 0.001
 I 5 (4.5%) 29 (3.2%)
 II 68 (61.3%) 696 (77.2%)
 III 38 (34.2%) 176 (19.5%)
Hepatitis B and/or C 19 (17.1%) 423 (46.9%) <0.001
Alanine aminotransferase (U/L) 97.9±114.8 91.6±129.8 0.623
Aspartate aminotransferase (U/L) 92.0±90.6 82.2±104.7 0.342
Total bilirubin (µmol/L) 105.1±125.7 65.9±107.4 0.003
Albumin (g/L) 36.8±6.5 38.4±5.2 0.003
White blood cells (×109/L) 6.5±2.6 6.0±2.7 0.029
Hemoglobin (g/L) 122.3±17.6 128.8±19.4 0.001
Platelet (×109/L) 179.5±66.3 173.3±85.9 0.112
Operation time (min) 268±64 261±83 0.082
Blood loss (mL) 541.9±459.4 678.9±751.1 0.061
Intraoperative transfusion 46 (41.4%) 413 (45.8%) 0.419
Pathological diagnosis
 Liver disease 0.166
  Hepatocellular carcinoma 37 (33.3%) 479 (53.2%)
  Intrahepatic cholangiocarcinoma 8 (7.2%) 50 (5.5%)
  Metastatic tumors 4 (3.6%) 32 (3.6%)
 Pancreas disease 0.656
  Adenocarcinoma 58 (52.3%) 295 (32.7%)
  Benign/borderline tumors 4 (3.6%) 45 (5.0%)
Surgical procedures <0.001
 Hepatectomy 49 (44.1%) 561 (62.3%)
 Pancreaticoduodenectomy 62 (55.9%) 340 (37.7%)
Types of hepatectomy 0.818
 Major hepatectomy 15 (30.6%) 163 (29.1%)
 Minor hepatectomy 34 (69.4%) 398 (70.9%)
 Vascular resection 4 (3.6%) 60 (6.7%) 0.298

Note: Continuous variables are expressed as mean ± SD and categorical variables as number (percentage).

Abbreviation: ASA, American Society of Anesthesiologists.